US Patent Issued to SHENZHEN KANGSU PHARMACEUTICAL TECHNOLOGY on Oct. 6 for "FGFR inhibitor compound and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,179, issued on Oct. 6, was assigned to SHENZHEN KANGSU PHARMACEUTICAL TECHNOLOGY Co. LTD. (China).

"FGFR inhibitor compound and use thereof" was invented by Liang Lu (Shanghai), Saisai Zhao (Jiyuan, China), Hai Huang (Zhengzhou, China), Longzheng Zhang (Xinmi, China), Jixuan Zhang (Dengfeng, China), Jiaxin Chen (Shenzhen, China) and Shancun Ling (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to FGFR inhibitor compounds and its use. Specifically, the present disclosure discloses a compound represented by formula (I), isotopically labeled compound thereof, or optical isomer thereof, geometric isomer there...